Differences in cognitive function and daily living skills between early- and late-stage schizophrenia

References

• Addington J, Saeedi H, Addington D. 2005. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res 78:35–43.
   PubMed Web of Science ®Google Scholar
• APA. 1994. Diagnostic and Statistical Manual of Mental Disorder. Washington, DC, American Psychiatric Association.
   Google Scholar
• Brune M, Abdel-Hamid M, Lehmkamper C, Sonntag C. 2007. Mental state attribution, neurocognitive functioning, and psychopathology: what predicts poor social competence in schizophrenia best? Schizophr Res 92:151–159.
   PubMed Web of Science ®Google Scholar
• Burton CZ, Vella L, Harvey PD, Patterson TL, Heaton RK, Twamley EW. 2013. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia. Schizophr Res 146:244–248.
   PubMed Web of Science ®Google Scholar
• Cohen CI, Cohen GD, Blank K, Gaitz C, Katz IR, Leuchter A, et al. 2000. Schizophrenia and older adults. An overview: directions for research and policy. Am J Geriatr Psychiatry 8:19–28.
   PubMed Web of Science ®Google Scholar
• Couture SM, Penn DL, Roberts DL. 2006. The functional significance of social cognition in schizophrenia: a review. Schizophr Bull 32 Suppl 1:S44–63.
   PubMed Web of Science ®Google Scholar
• Eckman PS, Shean GD. 2000. Impairment in test performance and symptom dimensions of schizophrenia. J Psychiatr Res 34: 147–153.
   PubMed Web of Science ®Google Scholar
• Figueira ML, Brissos S. 2011. Measuring psychosocial outcomes in schizophrenia patients. Curr Opin Psychiatry 24:91–99.
   PubMed Web of Science ®Google Scholar
• Fucetola R, Seidman LJ, Kremen WS, Faraone SV, Goldstein JM, Tsuang MT. 2000. Age and neuropsychologic function in schizophrenia: a decline in executive abilities beyond that observed in healthy volunteers. Biol Psychiatry 48:137–146.
   PubMed Web of Science ®Google Scholar
• Gardner DM, Murphy AL, O’Donnell H, Centorrino F, Baldessarini RJ. 2010. International consensus study of antipsychotic dosing. Am J Psychiatry 167:686–693.
   PubMed Web of Science ®Google Scholar
• Green MF, Bearden CE, Cannon TD, Fiske AP, Hellemann GS, Horan WP et al. 2012. Social cognition in schizophrenia, Part 1: performance across phase of illness. Schizophr Bull 38:854–864.
   PubMed Web of Science ®Google Scholar
• Green MF, Kern RS, Braff DL, Mintz J. 2000. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”? Schizophr Bull 26:119–136.
   PubMed Web of Science ®Google Scholar
• Green MF, Kern RS, Heaton RK. 2004. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72:41–51.
   PubMed Web of Science ®Google Scholar
• Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, et al. 2003. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl(416):16–23.
   Web of Science ®Google Scholar
• Harvey PD. 2013. Assessment of everyday functioning in schizophrenia: implications for treatments aimed at negative symptoms. Schizophr Res 150:353–355.
   PubMed Web of Science ®Google Scholar
• Harvey PD, Reichenberg A, Bowie CR, Patterson TL, Heaton RK. 2010. The course of neuropsychological performance and functional capacity in older patients with schizophrenia: influences of previous history of long-term institutional stay. Biol Psychiatry 67:933–939.
   PubMed Web of Science ®Google Scholar
• Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. 2001. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry 58:24–32.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Lindenmayer JP, Opler LA. 1986. Positive and negative syndromes in schizophrenia as a function of chronicity. Acta Psychiatr Scand 74:507–518.
   PubMed Web of Science ®Google Scholar
• Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13: 261–276.
   PubMed Web of Science ®Google Scholar
• Kee KS, Green MF, Mintz J, Brekke JS. 2003. Is emotion processing a predictor of functional outcome in schizophrenia? Schizophr Bull 29:487–497.
   PubMed Web of Science ®Google Scholar
• Keefe RS, Fox KH, Harvey PD, Cucchiaro J, Siu C, Loebel A. 2011. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial. Schizophr Res 125:161–168.
   PubMed Web of Science ®Google Scholar
• Lauriello J, Bustillo J, Keith SJ. 1999. A critical review of research on psychosocial treatment of schizophrenia. Biol Psychiatry 46: 1409–1417.
   PubMed Web of Science ®Google Scholar
• Liddle PF. 1987. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 17:49–57.
   PubMed Web of Science ®Google Scholar
• Markova IS, Roberts KH, Gallagher C, Boos H, McKenna PJ, Berrios GE. 2003. Assessment of insight in psychosis: a re-standardization of a new scale. Psychiatry Res 119:81–88.
   PubMed Web of Science ®Google Scholar
• Mausbach BT, Bowie CR, Harvey PD, Twamley EW, Goldman SR, Jeste DV et al. 2008. Usefulness of the UCSD performance- based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophrenia. J Psychiatr Res 42:320–327.
   PubMed Web of Science ®Google Scholar
• Mausbach BT, Depp CA, Bowie CR, Harvey PD, McGrath JA, Thronquist MH et al. 2011. Sensitivity and specificity of the UCSD Performance-based Skills Assessment (UPSA-B) for identifying functional milestones in schizophrenia. Schizophr Res 132: 165–170.
   PubMed Web of Science ®Google Scholar
• Mayer JD, Salovey P, Caruso DR, Sitarenios G. 2003. Measuring emotional intelligence with the MSCEIT V2.0. Emotion 3:97–105.
   PubMed Web of Science ®Google Scholar
• McCleery A, Ventura J, Kern RS, Subotnik KL, Gretchen-Doorly D, Green MF, et al. 2014. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment. Schizophr Res 157:33–39.
   PubMed Web of Science ®Google Scholar
• McGlashan TH. 1988. A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 14:515–542.
   PubMed Web of Science ®Google Scholar
• Moritz S, Andresen B, Jacobsen D, Mersmann K, Wilke U, Lambert M et al. 2001. Neuropsychological correlates of schizophrenic syndromes in patients treated with atypical neuroleptics. Eur Psychiatry 16:354–361.
   PubMed Web of Science ®Google Scholar
• Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. 2000. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scand 101:323–329.
   PubMed Web of Science ®Google Scholar
• Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD et al. 2008. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165:203–213.
   PubMed Web of Science ®Google Scholar
• Palmer BW, Heaton RK, Paulsen JS, Kuck J, Braff D, Harris MJ et al. 1997. Is it possible to be schizophrenic yet neuropsychologically normal? Neuropsychology 11:437–446.
   PubMed Web of Science ®Google Scholar
• Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. 2001. UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull 27:235–245.
   PubMed Web of Science ®Google Scholar
• Penn DL, Sanna LJ, Roberts DL. 2008. Social cognition in schizophrenia: an overview. Schizophr Bull 34:408–411.
   PubMed Web of Science ®Google Scholar
• Pinkham AE, Penn DL, Green MF, Buck B, Healey K, Harvey PD. 2014. The social cognition psychometric evaluation study: results of the expert survey and RAND panel. Schizophr Bull 40:813–823.
   PubMed Web of Science ®Google Scholar
• Rajji TK, Ismail Z, Mulsant BH. 2009. Age at onset and cognition in schizophrenia: meta-analysis. Br J Psychiatry 195:286–293.
   PubMed Web of Science ®Google Scholar
• Reichenberg A, Feo C, Prestia D, Bowie CR, Patterson TL, Harvey PD. 2014. The Course and Correlates of Everyday Functioning in Schizophrenia. Schizophr Res Cogn 1:e47–e52.
   PubMedGoogle Scholar
• Rey MJ, Schulz P, Costa C, Dick P, Tissot R. 1989. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 4:95–104.
   PubMed Web of Science ®Google Scholar
• Sharma T, Antonova L. 2003. Cognitive function in schizophrenia. Deficits, functional consequences, and future treatment. Psychiatr Clin North Am 26:25–40.
   PubMed Web of Science ®Google Scholar
• Slade E, Salkever D. 2001. Symptom Effects on Employment in a Structural Model of Mental Illness and Treatment: Analysis of Patients with Schizophrenia. J Ment Health Policy Econ 4:25–34.
   PubMedGoogle Scholar
• Sponheim SR, Jung RE, Seidman LJ, Mesholam-Gately RI, Manoach DS, O’Leary DS et al. 2010. Cognitive deficits in recent-onset and chronic schizophrenia. J Psychiatr Res 44:421–428.
   PubMed Web of Science ®Google Scholar
• Vohs JL, Lysaker PH, Francis MM, Hamm J, Buck KD, Olesek K et al. 2014. Metacognition, social cognition, and symptoms in patients with first episode and prolonged psychoses. Schizophr Res 153:54–59.
   PubMed Web of Science ®Google Scholar
• Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, An Der Heiden W et al. 2000. Social disability in schizophrenia: its development and prediction over 15 years in incidence cohorts in six European centres. Psychol Med 30:1155–1167.
   PubMed Web of Science ®Google Scholar
• Wilkinson G, Hesdon B, Wild D, Cookson R, Farina C, Sharma V et al. 2000. Self-report quality of life measure for people with schizophrenia: the SQLS. Br J Psychiatry 177:42–46.
   PubMed Web of Science ®Google Scholar